Altria and its peers have been grappling with a long-term decline in tobacco sales due to consumers switching to cheaper ...

Altria (NYSE:MO) reported earnings on Thursday that beat analyst expectations, but the tobacco giant was hit with a one-two ...

Indian biopharmaceutical firm Biocon is likely to list its key biosimilars business by March 2026 and aims for double-digit share in its core U.S. market for its new launches, a top executive told ...

The U.S. International Trade Commission ruled that the Altria-owned company’s vaping devices violate four of Juul’s patents.

By Sarah Ladd Kentucky Lantern The American Lung Association gave Kentucky mostly failing grades when it comes to preventing tobacco use — and helping people access recovery — in a 2025 report ...

Operator Good day, and welcome to the Altria Group 2024 fourth quarter and full year earnings conference call. [Operator ...

The main reason Altria stock pulled back was its guidance came up short. Management said adjusted earnings per share would grow 2% to 5%, reaching $5.22 to $5.37, which compares to the analyst ...

New regulations, a patent battle, and an illicit vape crisis threaten Altria's future--will its legendary dividends hold up?

Altria Group Inc.’s stock fell Thursday after the tobacco giant said it continues to face the challenge of counterfeit ...

Altria , the maker of Marlboro cigarettes, has placed under review its 2028 goals for selling alternatives to smoking on the ...

More images have emerged of the hundreds of illegal vapes, cigarettes and tobacco which were seized from several High Wycombe ...